Brief: Orexo Submits New Drug Application To FDA For Ox124

Orexo AB

18/09/2023 07:09

Sept 18 (Reuters) - Orexo AB  ORX.ST :
    * OREXO SUBMITS NEW DRUG APPLICATION TO FDA FOR OX124, A
HIGH-DOSE
RESCUE MEDICATION FOR OPIOID OVERDOSE
    * IF APPROVED, US LAUNCH IS EXPECTED TO BE INITIATED LATE IN
H2
2024 OR EARLY 2025
    * OX124 IS PROTECTED BY PATENTS UNTIL 2039

Source text for Eikon:  ID:nWkr6WNzKM 
Further company coverage:  ORX.ST 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com;  +48 58 769 66 00;))